Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 18/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 17/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 17/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 7/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
| ▸ | FPR2 | P25090 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2803315 | 0.93 | SLC6A4 (0.34) | SLC6A4SLC6A2SLC6A3MAPK1CYP2D6 | |
| SCHEMBL2805224 | 0.91 | SLC6A4 (0.33) | SLC6A4SLC6A2SLC6A3MAPK1CYP2D6 | |
| SCHEMBL2802815 | 0.88 | SLC6A2 (0.34) | SLC6A4SLC6A2SLC6A3CYP2D6CYP2C19 | |
| SCHEMBL2805897 | 0.88 | FFAR1 (0.34) | SLC6A4SLC6A2SLC6A3CYP2D6CYP2C19 | |
| SCHEMBL16351170 | 0.87 | MEN1 (0.37) | SLC6A4SLC6A2SLC6A3KCNH2 | |
| SCHEMBL17043983 | 0.84 | SLC6A2 (0.35) | SLC6A4SLC6A2SLC6A3CYP2D6CYP2C19 | |
| SCHEMBL2804693 | 0.84 | ALDH1A1 (0.36) | SLC6A4SLC6A2SLC6A3CYP2D6CYP2C19 | |
| SCHEMBL2808250 | 0.83 | MEN1 (0.39) | SLC6A4SLC6A3 | |
| SCHEMBL2803831 | 0.83 | LMNA (0.33) | SLC6A4SLC6A2SLC6A3CYP2D6CYP2C19 | |
| SCHEMBL2803902 | 0.82 | CYP2C19 (0.34) | SLC6A4SLC6A2SLC6A3CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8357694-B2 | Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds | ARQULE, INC. (US) | 2013-01-22 | — | — | US | disclosed |
| US-20100239525-A1 | SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS | ARQULE, INC. (US) | 2010-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239525-A1 | SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS | NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | SLC6A4 564/4885SLC6A2 233/4885SLC6A3 707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.